Tag: Aimmune Therapeutics

Notebooks, check. Backpack, check. Peanut allergy treatment, check. (Sponsored)

What if you could give your child a treatment option, in addition to practicing a strict peanut-free diet?
Palforzia Capsules with Logo

Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...

Safety and efficacy increased over time with treatment.
Oral Food Challenge

FARE Launches Global Research Competition to Develop a Safe, Compassionate Diagnostic...

$3 Million in prize money will inspire the world's leading food allergy researchers to put an end to the oral food challenge.
Palforzia Capsules with Logo

Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...

Majority of patients experienced low rates of adverse events which declined in frequency and severity with continued treatment.
Nestle Acquires Aimmune

Nestlé to Acquire Aimmune Therapeutics

Nestlé Health Science and Aimmune to create a global leader in food allergy prevention and treatment.
Upset Teen

Study Shows Negative Impact of Avoidance and Fear of Accidental Reactions...

The psychosocial impact of food allergies on children and teens is severe.
Palforzia

New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...

After 2 Years of Daily Treatment, More Than 80% of Patients Were Successfully Desensitized to 2000 mg Peanut Protein or Equivalent of About 14 Peanut Kernels.
Palforzia Capsules with Logo

Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...

The company warned that it has had to postpone in-person workshops to train physicians.
Palforzia Capsules with Logo

Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...

The FDA seeks to mitigate risks associated with treatment by mandating a program that must be followed by patients, prescribers, pharmacies, and healthcare settings.
Aimmune + Xencor

Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...

“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”